Filtered by Category: Lead Counsel
On November 3, 2021, U.S. District Judge Margo K. Brodie of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Richard Sun, Lead Plaintiff in Patel v. Koninklijke Philips N.V., 21-cv-4606 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Koninklijke Philips N.V. had deficient manufacturing controls and procedures that subjected it to product recalls, diminished revenue and potential legal action. Philips operates as a health technology company in North America, Greater China…
Read More
On November 2, 2021, U.S. District Judge Charles R. Breyer of the Northern District of California appointed Pomerantz LLP as Co-Lead Counsel on behalf of Huei-Ting Kang, Co-Lead Plaintiff in Kang v. Paypal Holdings, Inc., 21-cv-6468 (N.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that PayPal Holdings, Inc. failed to disclose deficiencies in its PayPal Credit debit and credit card services and the resulting non-compliance of these programs with applicable laws and regulations. PayPal operates as a technology platform and digital payments company…
Read More
On October 12, 2021, U.S. District Judge Julien Xavier Neals of the District of New Jersey appointed Pomerantz LLP as Co-Lead Counsel on behalf of John V. Levon, the Lead Plaintiff in In re CorMedix Inc. Securities Litigation, 20-cv-13819 (D.N.J.), a securities action brought on behalf of a class of defrauded investors concerning alleged material misrepresentations related CorMedix Inc.’s manufacturing process of its lead product candidate for the treatment of catheter-related bloodstream infections (“CRBSIs”). CorMedix is a biopharmaceutical company that focuses on developing and commercializing therapeutic…
Read More
On October 12, 2021, Justice Andrew Borrok of the Supreme Court of the State of New York appointed Pomerantz LLP as Lead Counsel on behalf of the class in Lorenzo, Michael James vs. BlueCity Holdings Limited, No. 652894/2021 (N.Y. Sup Ct.), a securities action brought on behalf of defrauded investors concerning alleged misstatements and misrepresentations made by BlueCity Holdings Limited in the Offering Documents for its July 2020 IPO. BlueCity is an online platform for the LGBTQ community, operating primarily in China, India, Korea, Thailand and Vietnam.
Read More
On September 15, 2021, U.S. District Judge Anthony J. Battaglia of the Southern District of California appointed Pomerantz LLP as Lead Counsel on behalf of Gergely Csaba, the Lead Plaintiff in Ali v. Franklin Wireless Corp., 21-cv-687 (S.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations related to the safety and commercial sustainability of Franklin Wireless Corp.’s Jetpack Hotspot mobile device. Franklin Wireless is a provider of hardware and software products that support wireless connectivity for home, business…
Read More
On September 16, 2021, U.S. District Judge Annemarie Carney Axon of the Northern District of Alabama (Eastern Division) appointed Pomerantz LLP as Co-Lead Counsel on behalf of the Lead Plaintiffs in Phillips v. Churchill Capital Corporation, 21-cv-539 (N.D. Ala.), a securities action brought on behalf of a class of defrauded investors concerning allegations related to statements made regarding the volume of automobiles to be produced following the merger of Churchill Capital Corporation IV and Lucid Motors, Inc. Churchill is a blank check company, also known as a special purpose acquisition…
Read More
On September 13, 2021, U.S. District Judge Gary Feinerman of the Northern District of Illinois (Eastern Division) appointed Pomerantz LLP as Lead Counsel for the Class on behalf of Marko Busic, the Lead Plaintiff in Busic v. Orphazyme A/S et al., 21-cv-3640 (N.D. Ill.), a securities action brought on behalf of a class of defrauded investors concerning allegations related to the efficacy and commercial prospects for Orphazyme A/S’s lead drug candidate arimoclomol. Orphazyme is a biopharmaceutical company that develops therapies for the treatment of neurodegenerative orphan diseases.
Read More
On August 20, 2021, U.S. District Judge John A. Kronstadt of the Central District of California appointed Pomerantz LLP as Lead Counsel on behalf of Anthony Sanchez and Thomas Tossavainen, the Co-Lead Plaintiffs in Anthony Sanchez v. Decision Diagnostics Corp., et al. 21-cv-418 (C.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations related to Decision Diagnostics Corp.’s claims that they developed a finger-prick blood test that could detect COVID-19 in one minute.
Read More
On August 5, 2021, U.S. Magistrate Judge Gregory J. Kelly of the Middle District of Florida (Orlando Division) appointed Pomerantz LLP as Lead Counsel on behalf of Robert and Mariusz Ciecko, the Lead Plaintiff in Theodore v. PureCycle Technologies, Inc. et al., 6:21-cv-809 (M.D. Fla.), a securities action brought on behalf of a class of defrauded investors concerning allegations that PureCycle Technologies, Inc. had based its “ground-breaking, patented recycling process” on unproven technology and its financial projections were baseless.
Read More
On July 21, 2021, U.S. District Judge Mark C. Scarsi of the Central District of California appointed Pomerantz LLP as Lead Counsel on behalf of Betty Jo Pheiffer, the Lead Plaintiff in Montag v. Volkswagen AG, No. 21-cv-3678 (C.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Volkswagen AG had misled investors in regard to the true nature of its rebranding as “Voltswagen” as just an April Fool’s Day joke.
Read More
On June 22, 2021, U.S. District Judge William Alsup of the Northern District of California appointed Pomerantz LLP as Lead Counsel on behalf of the Hawaii Employees' Retirement System, the Lead Plaintiff in Mullen v. Wells Fargo & Company et al., 20-cv-7997 (N.D. Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Wells Fargo & Company had misled investors about the strength of its commercial loan operations and failed to follow appropriate underwriting…
Read More
On June 16, 2021, U.S. District Judge Robert J. Colville of the Western District of Pennsylvania appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Hugh Melnick in Jacobowitz v. Range Resources Corporation, No. 21-cv-301 (W.D. Pa.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Range Resources Corporation improperly reported the status of wells it owns and operates in Pennsylvania.
Read More
On June 11, 2021, U.S. District Judge Valerie Caproni of the Southern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Brian Pavlick in Pavlick v. Repro Med Systems, Inc., 21-cv-2632 (S.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Repro Med Systems, Inc. d/b/a KORU Medical Systems (“KORU” or the “Company”) materially misled investors by failing to disclose that..
Read More
On June 2, 2021, U.S. District Judge Karen Gren Scholer of the Northern District of Texas – Dallas Division appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Mohsen Javaherneshan in Javaherneshan v. MoneyGram International, Inc., 21-cv-815 (N.D. Tex.), a securities action brought on behalf of a class of defrauded investors concerning allegations that MoneyGram International, Inc. failed to disclose risks…
Read More
On May 20, 2021, U.S. District Judge Michael M. Baylson of the Eastern District of Pennsylvania granted class certification to investors and appointed Pomerantz LLP as Co-Lead Class Counsel in Pelletier v. Endo International plc et al, 2:17-cv-05114 (E.D. Pa.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Endo International plc inflated its revenue from generic pharmaceuticals by misrepresenting its pricing practices.
Read More
On April 28, 2021, U.S. District Judge J. Paul Oetken of the Southern District of New York appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiff Nuggehalli Balmukund Nandkumar in In re AstraZeneca plc Sec. Litig., 21-cv-722 (S.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that AstraZeneca plc failed to disclose to investors that its clinical trials…
Read More
On April 19, 2021, U.S. District Judge Kiyo A. Matsumoto of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiffs Yasser Abed and Evay Avbenake in Cushman v. Fortress Biotech, Inc., 20-cv-5767 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Fortress Biotech, Inc. failed to disclose that IV Tramadol…
Read More
On April 8, 2021, U.S. District Judge David O. Carter of the Central District of California (Western Division) appointed Pomerantz LLP as Co-Lead Counsel on behalf of Co-Lead Plaintiffs Betty Kalmanson, Lawrence Kalmanson and Shawn Kalmanson in In re GoodRx Holdings, Inc. Securities Litigation, 2:20-cv-11444-DOC-PD (C.D.Cal.), a securities action brought on behalf of a class of defrauded investors concerning allegations that GoodRx Holdings…
Read More
On March 17, 2021, U.S. Magistrate Judge Roanne L. Mann of the Eastern District of New York appointed Pomerantz LLP as Lead Counsel on behalf of Lead Plaintiff Lawrence Kelemen in In re Northern Dynasty Minerals Ltd. Sec. Litig., 20-cv-5917 (E.D.N.Y.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Northern Dynasty Minerals, Inc. misled investors regarding the compliance…
Read More
On March 11, 2021, Chief U.S. District Judge K. Michael Moore of the Southern District of Florida appointed Pomerantz LLP as Co-Lead Counsel on behalf of Lead Plaintiff Paul J. Graney in Graney v. Restaurant Brands International, Inc., 21-cv-20508 (S.D. Fla.), a securities action brought on behalf of a class of defrauded investors concerning allegations that Restaurant Brands International misled investors…
Read More
